Over 30 minutes, this webinar will investigate:

• Impact of process changes for recombinant therapeutics
• When are comparability studies required
• Which scope is expected for biotech products
• Five steps to succeed in comparability

This webinar will be led by Dr Robert Zoubek, an expert in the development, manufacturing, and analytics of biologics, as well as regulatory affairs. Robert is a Senior Consultant at Granzer Regulatory Affairs & Services.

свернуть